Volufiline Market Report: Sales Volume, Market Share, Leading Brands & Market Trends

medicube is the best-performing volufiline brand in July 2026, moving 210,000 units across 3 ASINs for 43.8% of Top 10 volume. celimax follows with 100,000 units (20.8%), ahead of Dr.Melaxin on 70,000 units (14.6%).

With 8 brands splitting the Top 10 and 79.2% of volume sitting with three of them, this is a concentrated shelf — the leaders hold multiple listings or one very high-velocity ASIN, so a new entrant competes against established review moats rather than an open field. Average selling prices among the leaders run from $17.00 to $22.90, which frames the price band a competing listing has to justify.

Based on July 2026 data, this shortlist surfaces the two kinds of ASIN worth keeping an eye on — the ones that just broke into the Top 10, and the ones growing fastest month over month. Specifically, one ASIN forced its way in: B0GVQ6NYR3 booked 50K units at $29.90. On the growth side, B0GV4424F8 leads positive momentum with ▲ 185.7% MoM growth on 2K units, with B0H1PTRVT8 close behind at ▲ 150.0% MoM on 500 units.

The two signals carry different weight. A fresh entrant means share has already changed hands — an incumbent gave up its place to make room, so any competitive set drawn up a month ago is now out of date. A steep growth rate works as the earlier warning: it marks demand that is still compounding, usually a month or two before the ranking catches up to it.